TABLE 2.
Treatment and Procedural Details
| USAT (n = 40) | SCDT (n = 41) | Total (n = 81) | P Value | |
|---|---|---|---|---|
| Contraindications to lysis | 0.37 | |||
| Minor | 8 (20) | 6 (15) | 14 (17) | |
| Major | 0 | 0 | ||
| PA systolic pressure, mm Hg | 55 ± 15 | 57 ± 16 | 56 ± 15 | 0.55 |
| PA diastolic pressure, mm Hg | 26 ± 10 | 25 ± 8 | 25 ± 9 | 0.63 |
| PA mean pressure, mm Hg | 37 ± 10 | 37 ± 10 | 37 ± 10 | 0.91 |
| On-table bolus tPA | 23 (58) | 26 (63) | 49 (61) | 0.38 |
| On-table bolus tPA dose, mg* | 0.53 | |||
| Mean | 3 ± 3 | 3 ± 4 | 3 ± 4 | |
| Median (IQR) | 2 (4) | 2 (4) | 2 (4) | |
| Total tPA dose | 0.53 | |||
| Mean | 19 ± 7 | 18 ± 7 | 19 ± 7 | |
| Median (IQR) | 20 (11) | 18 (11) | 19 (10) | |
| Total hours of tPA drip | 0.99 | |||
| Mean | 14 ± 5 | 14 ± 6 | 14 ± 6 | |
| Median (IQR) | 12 (9) | 14 (10) | 13 (11) |
Values are n (%), mean ± SD, median (IQR).
*
For those who received on-table tPA.
IQR = interquartile range; PA = pulmonary artery; tPA = tissue plasminogen activator; other abbreviations as in Table 1.